Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular drugs during pregnancy.

B B Little1, L C Gilstrap

  • 1Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas 75235-9032.

Clinical Obstetrics and Gynecology
|March 1, 1989
PubMed
Summary

Most cardiac medications are likely safe for pregnant patients, with the condition posing a greater risk than the drugs. Treatment should not be withheld due to pregnancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Links between oral health-related quality of life in US adults and type 2 diabetes: structural equation modeling analysis.

Community dental health·2021
Same author

Blood lead levels and growth status of children.

American journal of human biology : the official journal of the Human Biology Council·2017
Same author

Environmental influences cause menstrual synchrony, not pheromones.

American journal of human biology : the official journal of the Human Biology Council·2017
Same author

Lithium During Pregnancy : Drug Effects and Their Therapeutic Implications.

CNS drugs·2016
Same author

Physical fitness of normal, stunted and overweight children 6-13 years in Oaxaca, Mexico.

European journal of clinical nutrition·2011
Same author

Blood lead levels and growth status among African-American and Hispanic children in Dallas, Texas--1980 and 2002: Dallas Lead Project II.

Annals of human biology·2009

Area of Science:

  • Cardiology
  • Pharmacology
  • Maternal-Fetal Medicine

Background:

  • Limited data exists on the fetal risks associated with many cardiac medications.
  • Clinical necessity has led to experience with numerous cardiac drugs during pregnancy.

Purpose of the Study:

  • To assess the safety of cardiac medications during pregnancy.
  • To inform clinical practice regarding the management of cardiac conditions in pregnant individuals.

Main Methods:

  • Review of existing clinical experience and data on cardiac drug use in pregnancy.
  • Comparative risk assessment between cardiac disease and medication effects.

Main Results:

  • Clinical experience suggests most cardiac medications are probably safe for use in pregnancy.
  • The underlying cardiac condition often presents a greater risk to the mother and fetus than the prescribed medications.

Conclusions:

  • Cardiac medications indicated for treatment should not be withheld solely based on pregnancy.
  • The risks associated with untreated cardiac disease in pregnancy generally outweigh the potential risks of necessary medications.

Related Experiment Videos